Bio-Techne's 2025 Sustainability Report: Innovations Advancing Health and the Environment
Bio-Techne Corporation recently unveiled its 2025 Corporate Sustainability Report, highlighting the company's dedication not only to advancing human health but also to protecting our planet. As a key player in life sciences, Bio-Techne aims to improve life quality through scientific and medical advancements. Kim Kelderman, the company's President and CEO, stated that the intertwined relationship between human health and environmental stewardship is at the core of their mission.
In its report, Bio-Techne outlined several key achievements and ambitious goals. A major highlight includes ongoing advancements in treatments and diagnostics related to cancers, diabetes, neurodegenerative disorders, autoimmune diseases, and rare illnesses. These breakthroughs are transforming healthcare for millions globally, showcasing the company's commitment to innovation.
Significantly, Bio-Techne has achieved an impressive 40% reduction in Scope 1 and 2 emissions across its operations. This reduction is primarily driven by transitioning to 100% renewable electricity at its headquarters in Minneapolis. This initiative underscores the company's commitment to environmental responsibility and sets a roadmap towards further sustainable practices.
Looking ahead, Bio-Techne has committed to establishing science-based targets for reducing Scope 1, 2, and 3 greenhouse gas emissions, with plans to submit these targets for validation by the Science Based Targets Initiative (SBTi) in 2026. This strategic move reflects the company's determination to align itself with global climate goals.
Moreover, Bio-Techne's report highlights enhanced governance measures, including comprehensive oversight of artificial intelligence practices by its Board, and the completion of a double materiality assessment to better inform sustainability priorities. This ensures that sustainability is not just a compliance matter but is integrated deeply into the company's operational strategies.
Furthermore, Bio-Techne's investment in organizational culture and employee development is noteworthy. With initiatives grounded in their EPIC values – Empowerment, Passion, Innovation, and Collaboration – the company is fostering a workplace that prioritizes continuous learning and growth. This investment is likely to lead to greater employee satisfaction and retention.
Bio-Techne's sustainability efforts extend to its product lines as well, with innovations aimed at improving efficiency and resource management in life sciences tools, proteomic instruments, spatial biology, and precision diagnostics. The company recognizes that responsible scientific advancement starts with its workforce, emphasizing the importance of diverse perspectives in driving sustainable innovation.
"Our customers trust us to advance science responsibly, and we know that starts with our people," said Kelderman. By prioritizing environmental protection and community support, Bio-Techne aims to create a lasting impact on both healthcare and the industries it serves.
The complete 2025 Sustainability Report can be accessed on Bio-Techne's official website, showcasing their commitment to corporate social responsibility. With over $1.2 billion in net sales for fiscal 2025 and a workforce of approximately 3,100 employees worldwide, Bio-Techne Corporation stands at the forefront of innovation in life sciences, constantly seeking to address the urgent challenges posed by climate change and public health crises.
In its report, Bio-Techne outlined several key achievements and ambitious goals. A major highlight includes ongoing advancements in treatments and diagnostics related to cancers, diabetes, neurodegenerative disorders, autoimmune diseases, and rare illnesses. These breakthroughs are transforming healthcare for millions globally, showcasing the company's commitment to innovation.
Significantly, Bio-Techne has achieved an impressive 40% reduction in Scope 1 and 2 emissions across its operations. This reduction is primarily driven by transitioning to 100% renewable electricity at its headquarters in Minneapolis. This initiative underscores the company's commitment to environmental responsibility and sets a roadmap towards further sustainable practices.
Looking ahead, Bio-Techne has committed to establishing science-based targets for reducing Scope 1, 2, and 3 greenhouse gas emissions, with plans to submit these targets for validation by the Science Based Targets Initiative (SBTi) in 2026. This strategic move reflects the company's determination to align itself with global climate goals.
Moreover, Bio-Techne's report highlights enhanced governance measures, including comprehensive oversight of artificial intelligence practices by its Board, and the completion of a double materiality assessment to better inform sustainability priorities. This ensures that sustainability is not just a compliance matter but is integrated deeply into the company's operational strategies.
Furthermore, Bio-Techne's investment in organizational culture and employee development is noteworthy. With initiatives grounded in their EPIC values – Empowerment, Passion, Innovation, and Collaboration – the company is fostering a workplace that prioritizes continuous learning and growth. This investment is likely to lead to greater employee satisfaction and retention.
Bio-Techne's sustainability efforts extend to its product lines as well, with innovations aimed at improving efficiency and resource management in life sciences tools, proteomic instruments, spatial biology, and precision diagnostics. The company recognizes that responsible scientific advancement starts with its workforce, emphasizing the importance of diverse perspectives in driving sustainable innovation.
"Our customers trust us to advance science responsibly, and we know that starts with our people," said Kelderman. By prioritizing environmental protection and community support, Bio-Techne aims to create a lasting impact on both healthcare and the industries it serves.
The complete 2025 Sustainability Report can be accessed on Bio-Techne's official website, showcasing their commitment to corporate social responsibility. With over $1.2 billion in net sales for fiscal 2025 and a workforce of approximately 3,100 employees worldwide, Bio-Techne Corporation stands at the forefront of innovation in life sciences, constantly seeking to address the urgent challenges posed by climate change and public health crises.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.